Type 2 diabetes, cardiovascular risk, and the link to insulin resistance

Medicine and Dentistry

• Apoplexy 25%
• Atherosclerosis 25%
• Blood Pressure 25%
• C Reactive Protein 25%
• Cardiovascular Disease 25%
• Cardiovascular Risk 75%
• Cardiovascular System 75%
• Chemotherapeutic Agent 25%
• Combination Therapy 50%
• Complication 25%
• Diabetes 50%
• Drug 25%
• Dyslipidemia 50%
• Edema 25%
• Fibrinolysis 25%
• Health Outcomes 25%
• Hyperglycemia 75%
• Hypertension 75%
• Insulin Resistance 50%
• Insulin Sensitizing Agent 25%
• Liver Toxicity 25%
• Macrovascular Disease 50%
• Maturity Onset Diabetes of the Young 75%
• Metabolic Syndrome 25%
• Microalbuminuria 50%
• Microangiopathy 50%
• Myocardial Infarction 25%
• Obesity 75%
• Patient with Type 2 Diabetes 100%
• Pioglitazone 25%
• Plasminogen Activator Inhibitor-1 25%
• Retinopathy 25%
• Risk Reduction 25%
• Rosiglitazone 25%
• Sequela 25%
• Serositis 25%
• Symptom 25%
• Therapeutic Procedure 25%
• Thiazolidinedione 75%
• Vasculitis 25%